Medtronic Cuts Annual Profit Forecast on Forex Hit

Reuters2022-11-22

Nov 22 (Reuters) - Medtronic Plc on Tuesday lowered its full-year profit outlook, blaming a stronger dollar and a slower-than-anticipated recovery from supply chain disruptions.

Shares of the Dublin-based company fell nearly 2.5% before the bell.

The medical device maker now sees its adjusted profit in the range of $5.25 to $5.30 per share for fiscal 2023, compared with $5.53 to $5.65 previously expected.

During the year, the ongoing shortage of semiconductor chips and a stronger dollar have heavily impacted Medtronic's medical surgical unit - which sells stapling and dissection devices - as well as its spinal unit.

Other medical device makers such as Boston Scientific Corp and Stryker(SYK.N)have also cautioned about the persistence of supply chain constraints and the stronger dollar in the near term.

Medtronic's net income fell to $427 million, or 32 cents per share, in its second quarter ended Oct. 28, from $1.31 billion, or 97 cents per share, a year earlier.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Leave a comment
2